Quarterly report pursuant to Section 13 or 15(d)

Non-Controlling Interests (Details)

v3.20.1
Non-Controlling Interests (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Noncontrolling Interest [Line Items]      
NCI equity share $ 49,755   $ 108,017
Net loss attributable to non-controlling interests (11,698) $ (17,647) (61,700)
Non-controlling interests in consolidated entities 38,057   46,317
Aevitas [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share (1,989)   (1,249)
Net loss attributable to non-controlling interests (186)   (694)
Non-controlling interests in consolidated entities $ (2,175)   $ (1,943)
Non-controlling ownership 35.80%   35.80%
Avenue [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ 5,419   $ 24,269
Net loss attributable to non-controlling interests (955)   (19,011)
Non-controlling interests in consolidated entities $ 4,464   $ 5,258
Non-controlling ownership 77.30%   77.30%
Baergic[Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ (1,201)   $ 23
Net loss attributable to non-controlling interests (3)   (1,162)
Non-controlling interests in consolidated entities $ (1,204)   $ (1,139)
Non-controlling ownership 33.00%   33.00%
Cellvation [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ (917)   $ (732)
Net loss attributable to non-controlling interests (38)   (158)
Non-controlling interests in consolidated entities $ (955)   $ (890)
Non-controlling ownership 20.60%   20.60%
Checkpoint [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ 15,121   $ 29,389
Net loss attributable to non-controlling interests (2,403)   (14,687)
Non-controlling interests in consolidated entities $ 12,718   $ 14,702
Non-controlling ownership 78.40%   78.00%
Coronado SO [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ (290)   $ (290)
Net loss attributable to non-controlling interests     0
Non-controlling interests in consolidated entities $ (290)   $ (290)
Non-controlling ownership 13.00%   13.00%
Cyprium [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ (795)   $ (320)
Net loss attributable to non-controlling interests (89)   (99)
Non-controlling interests in consolidated entities $ (884)   $ (419)
Non-controlling ownership 18.90%   10.60%
Helocyte [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ (4,700)   $ (4,322)
Net loss attributable to non-controlling interests (165)   (402)
Non-controlling interests in consolidated entities $ (4,865)   $ (4,724)
Non-controlling ownership 18.80%   19.30%
JMC [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ 118   $ (211)
Net loss attributable to non-controlling interests 159   325
Non-controlling interests in consolidated entities $ 277   $ 114
Non-controlling ownership 6.90%   6.90%
Mustang [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ 39,640   $ 62,025
Net loss attributable to non-controlling interests (8,008)   (25,727)
Non-controlling interests in consolidated entities $ 31,632   $ 36,298
Non-controlling ownership 69.00%   70.30%
Tamid [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ (651)   $ (565)
Net loss attributable to non-controlling interests (10)   (85)
Non-controlling interests in consolidated entities $ (661)   $ (650)
Non-controlling ownership 22.80%   22.80%